BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

WaveTec Vision Announces VerifEye™ - a New Hardware Upgrade for the ORA System® ; Preview at ASCRS Annual Symposium April 19-23


4/16/2013 10:31:44 AM

SAN FRANCISCO, CA--(Marketwired - April 16, 2013) -

WaveTec Vision's proprietary ORA System®, which is now being used to improve the accuracy of cataract surgery in more than 5,000 procedures each month, is undergoing a significant upgrade that provides critical feedback on eye stability. VerifEye™ is a new monitoring system that provides ophthalmic surgeons continuous refractive information for more refined visual outcomes.

"The data on VerifEye is exceeding our expectations," said Tom Frinzi, WaveTec President and CEO. "Even the most experienced ORA surgeons are seeing a significant improvement in patient outcomes with VerifEye."

With the ORA System relied on by high-volume cataract surgeons nationwide, WaveTec has increased its annual projection for ORA-Guided cataract surgery to more than 60,000 procedures for the year. This represents roughly two percent of all U.S. cataract procedures, after only 16 months of commercialization.

"I've always had great results with the ORA System, and with the addition of VerifEye we're now seeing LASIK-like results in cataract surgery," said Dr. Robert Cionni, who practices in Salt Lake City, UT. "Of the VerifEye cases we've done to-date, 92 percent of patients were within .50 diopters of intended target, which is truly remarkable."

VerifEye is the most significant upgrade yet to the ORA System. VerifEye enables surgeons to confirm that the eye is stable prior to the measurement by providing streaming refractions in the preview screen, which surgeons consider a tremendous benefit. The ophthalmic community will have the chance to see VerifEye in action in Booth #416 at the ASCRS annual symposium, April 19-23.

About WaveTec Vision
WaveTec Vision, a privately held company, is the leader in intraoperative wavefront measurement technology for refractive cataract surgeons, providing on-demand information that enables the best possible vision for patients. Based in Aliso Viejo, Calif., its proprietary ORA System is a revolutionary diagnostic device that takes intraoperative wavefront aberrometry to a new level of performance. For demanding patients and the skilled surgeons who serve them, the ORA System delivers optimal cataract surgery results. For more information visit www.wavetecvision.com.


Contact:
Kimberly Capwell
CEO
CAPWELL COMMUNICATIONS
260 Newport Center Drive #311
Newport Beach CA 92660
p 949.999.3303
f 949.333.1467
www.capwellcommunications.com
Twitter: CAPWELLcomm

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES